The PharmaSafe research group is proud to announce its involvement in new groundbreaking publications that explore the effectiveness of COVID-19 vaccines in preventing long COVID. These publications were published in Lancet Respiratory Medicine, a world-leading respiratory medicine and critical care journal with an impressive Impact Factor of 76·2.
The latest publication, led by Nhung Trinh and other collaborators, draws on extensive data from Norway to examine the effectiveness of COVID-19 vaccines in mitigating long-term symptoms of the virus. This publication builds upon a prior study carried out by an international consortium of researchers, which explored the effectiveness of COVID-19 vaccines in preventing long COVID symptoms in the UK, Spain, and Estonia. The collaborative effort not only underscores the global relevance of the research findings but also contributes to a growing body of evidence on the potential protective effects of vaccination against long COVID.
Interpreting these studies, the authors find consistent evidence that vaccination against COVID-19 reduces the risk of long COVID symptoms. These findings emphasize the importance of vaccination in preventing persistent COVID-19 symptoms, particularly in adults.
The PharmaSafe research group is proud to have played a role in this collective effort, furthering our commitment to advancing public health and pharmaceutical research. By applying scientific rigor and innovative approaches, our researchers have made significant contributions to the understanding of COVID-19 vaccine effectiveness and long-term health outcomes.
The PharmaSafe research group extends its gratitude to all the collaborators and researchers involved in these publications, as well as the Lancet Respiratory Medicine for providing an exceptional platform to share these impactful findings with the global medical community.
For further details, the publications can be accessed via the following links:
Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, Daniel Prieto-Alhambra, Hedvig ME Nordeng. Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. The Lancet Respiratory Medicine, 2024, ISSN 2213-2600, https://doi.org/10.1016/S2213-2600(24)00082-1.
Martí Català, Núria Mercadé-Besora, Raivo Kolde, Nhung T H Trinh, Elena Roel, Edward Burn, Trishna Rathod-Mistry, Kristin Kostka, Wai Yi Man, Antonella Delmestri, Hedvig M E Nordeng, Anneli Uusküla, Talita Duarte-Salles, Daniel Prieto-Alhambra, Annika M Jödicke. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. The Lancet Respiratory Medicine, Volume 12, Issue 3, 2024, Pages 225-236, ISSN 2213-2600, https://doi.org/10.1016/S2213-2600(23)00414-9.